The company’s net sales, when broken out, show net sales for the surgical implant segment were $18.1 million in the second quarter, reflecting an increase of 10.2 percent over net sales in the second quarter of 2011. Mike Mogul, DJO’s president and chief executive officer, attributed the increased sales to strong sales of new products.
More Articles on Orthopedic Devices:
Study to Compare Benvenue Medical, Medtronic Spinal Systems
National Capital Region Medical Adopts HemaClear Device
Medtronic Receives 510(k) Approval for Orthopedic Sealer
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.